4 novinky
OpenAI is acquiring Orchestra Bio, a four-year-old startup whose AI agents help biopharma teams handle operational drug development tasks; the team will join Rosalind, OpenAI's life sciences platform serving Moderna and Novo Nordisk.
Pre-IPO disclosures show Eric Schmidt holds roughly half the Anthropic stake of CEO Dario Amodei. The Wall Street Journal separately reported $16.3 billion in H1 2026 revenue, ~$9 billion in compute spending over six months, and over $600 billion in future infrastructure commitments.
Citadel founder Ken Griffin told the Future of Global Markets Conference that investors are almost certainly in the middle of an AI bubble, warning that current enthusiasm echoes past technology cycles.
Anthropic is in advanced talks for a $45 billion compute commitment with cloud infrastructure provider Nscale, but the deal depends on securing financing and enough electricity for the hardware, according to The Neuron.
